Osteoporosis is an osteolytic disease resulted from imbalance in bone homeostasis. Studies indicated that N-myc downstream-regulated gene 2 (NDRG2) could affect the osteoclast differentiation. However, the effect of NDRG2 on osteoblastic differentiation and calcification remains unknown. Hence, we aimed to analyze the effect of NDRG2 on the proliferation and differentiation of osteoblasts.
Background
Osteoporosis is a systemic metabolic osteopathy characterized by the decreased bone mass and degradation of bone microstructure. The osteoporosis risk is estimated to be approximately 72% for women and 62% for men, who are older than 50 years of age [1, 2] . With the speeding up of aging, osteoporosis has become a common and frequently occurring disease in the world. According to the results of China's 2013 population census, the number of patients with osteoporosis or low bone density in China will reach 212 million [3] . The absolute number of osteoporosis patients in China shows an obvious rising trend, seriously endangering the health and quality of life of middle-aged and elderly people. Although some drugs for the treatment of osteoporosis have curative effects, some drugs still have the varying degree side effect. Therefore, it is extremely urgent to find a new drug for the effective treatment of osteoporosis. N-myc downstream regulator gene 2 (NDRG2) is involved in cell growth and differentiation hormone response [4] [5] [6] . Tamura et al. [7] studied role of NDRG2 in oral squamous cell carcinoma and found that NDRG2 overexpression inhibited the PI3K/AKT and NF-kB signaling pathways to suppress the epithelial-mesenchymal transformation of oral squamous cell carcinoma. NDRG2 is also related to osteoclast differentiation. Kim et al. [8] indicated that NDRG2 could inhibit the breast cancer induced osteoclast differentiation by downregulation of intercellular adhesion molecule 1 (ICAM1). Kang et al. [9] showed that NDRG2 potentially inhibited osteoclast differentiation and regulated the signal transduction pathway related to osteoclastogenesis. However, its role in osteoblast differentiation is unknown.
Hence, we aimed to analyze the effect of NDRG2 on the proliferation and differentiation of osteoblasts.
Material and Methods
Cell culture and cell treatment MC3T3-E1 cells were purchased from American Type Culture Collection (Rockville, MD, USA) and grew in DMEM medium containing 15% fetal bovine serum in an environment containing 5% CO 2 at 37°C. MC3T3-E1 cells were induced by 300 ng/mL bone morphogenetic protein 2 (BMP2) for 14 days and cell differentiation was observed by a microscope at day 0, 7, and 14.
Real-time quantitative polymerase chain reaction (RT-qPCR) analysis
MC3T3-E1 cells were collected after BMP2 induction or transfection. Total RNA of cells was extracted with TRIzol kit (Invitrogen; Thermo Fisher Scientific, Inc.), and its concentration and purity were detected. The cDNA was synthesized with reverse transcription kit (Takara Biotechnology Co., Ltd., Beijing, China), and the operation procedure was strict in accordance with the instructions of reverse transcription kit. After the concentration of cDNA was adjusted, the Master Mix of SYBR Green RT-qPCR (Invitrogen; Thermo Fisher Scientific, Inc.) was used for PCR reaction. Reaction condition is as follows: 94°C predenaturation for 5 minutes, 94°C denaturation for 10 seconds, 56°C annealing for 30 seconds, 72°C extension for 30 seconds, a total of 40 cycles, and 72°C terminal extension for 10 minutes. GAPDH was an internal control and the 2 -DDCt method to calculate the mRNA expression of runt-related transcription factor 2 (Runx2), osteoprotegerin (OPG), osterix (OSX), and osteocalcin (OCN) and NDRG2 in MC3T3-E1 cells. The primer sequences for qPCR were as follows: GAPDH forward, 5'-AAGTTCAACGGCACAGTCAAGG-3', and reverse, 5'-ACGCCAGTAGACTCCACGACAT-3'; Runx2 forward, 5'-GAACCAAGAAGGCACAGACAGAA-3', and reverse, 5'-GGCGGGACACCTACTCTCATACT-3'; OPG forward, 5'-CCTTGCCCTGACCACTAC-3', and reverse, 5'-TCATTTGAGAAGAACCCATC-3'; OSX forward, 5'-GACTCAACAGCCCTGGGAAAA-3', and reverse, 5'-GGGTGGGTAGTCATTGGCATAG-3'; OCN forward, 5'-GCCCTCACACTCCTCGCC-3', and reverse, 5'-TCTTCACTACCTCGCTGCCC-3'; NDRG2 forward, 5'-CAGGACAAACACCCGAGACT-3', and reverse, 5'-AGCCATAAGGTGTCTCCACAG-3'.
Western blot analysis
After phosphate-buffered saline (PBS) washed the cells with PBS for 3 times, the pre-cooled lysate was added to MC3T3-E1 cells, which was placed on ice for full lysis and centrifuged at 48 000 rpm for 10 minutes to remove the supernatant. The protein concentration was determined with bicinchoninic acid (BCA) protein concentration detection kit (Pierce; Thermo Fisher Scientific, Inc.). The protein was mixed with loading buffer with a volume ratio of 1: 4, which was heated in boiling water for 10 minutes to make protein denaturation. 30 μg denatured protein samples per hole was performed with gel electrophoresis separation (100 g/L separating gel and 50 g/L stacking gel) for 2 hours at the electrophoretic conditions of 110 V constant voltage. After electrophoresis, western transfer was conducted at 250 mA constant flow at 4°C for 2 hours. After that, membrane was incubated in the 50 g/L of bovine serum albumin at 25°C for 2 hours. Then, membrane was incubated overnight at 4°C with primary The membrane was color-developing with enhanced chemiluminescence (ECL) and detected with an ECL detection system (Thermo Fisher Scientific, Inc.). GAPDH was an internal control and the experiment was repeated three times.
Cell transfection
MC3T3-E1 cells were seeded in 6-well plates and placed in 37°C incubators for further culture. When the cells grew to 50% confluence, then pcDNA-NC, pcDNA-NDRG2, shRNA-NC, shRNA-NDRG2-1, and shRNA-NDRG2-2 were transfected with Lipofectamine 2000 transfection reagent, respectively.
MC3T3-E1 cells receiving no transfection were recorded as control group. These MC3T3-E1 cells were continually cultured in 37°C incubators.
Alkaline phosphatase (ALP) activity assay
Alkaline phosphatase (ALP) activity was measured by ALP activity kit (Beyotime, Shanghai, China). The absorbance value was determined by enzyme-linked immunoassay at the wavelength of 490 nm and ALP was evaluated according to the absorbance value.
Alizarin red staining
The mineralization nodules were assessed by alizarin red staining assay. After PBS washed cells with PBS for 3 times, 4% paraformaldehyde was added to fix the cells and the cells were stained at 25°C for 30 minutes. After PBS washed the cells twice, 2% alizarin red stain was added to stain the cells. The cells were stained at 25°C for 15 minutes and the staining fluid was removed. The cells were washed with distilled water for 3 times and the staining results were observed. Statistical analysis SPSS 22.0 statistical software was used for data analysis. The experimental results were in the form of mean±standard deviation. We used the t-test can compare the difference between 2 groups. One-way analysis of variance (ANOVA) can analyze the difference between the multiple groups with least significant difference (LSD)-t method. P<0.05 meant that the difference was statistically significant.
Results

NDRG2 expression is increased in BMP2-induced MC3T3-E1 cells
The differentiation of MC3T3-E1 cells induced by BMP2 at day 0, 7, and 14 was observed by a microscope. The results of Figure 1A indicated that MC3T3-E1 cells differentiation was increased with the induction time of BMP2. And the expression of cell differentiation-related proteins (Runx2, OPG, OSX, and OCN) was all increased with the induction time of BMP2 ( Figure 1B-1F) . With the induction time of BMP2 for MC3T3-E1 cells, NDRG2 expression was obviously increased in BMP2-induced MC3T3-E1 cells (Figure 1G, 1H ).
Upregulation and downregulation of NDRG2 affects the osteoblast differentiation
Compared with the control group and pcDNA-NC group, NDRG2 expression was upregulated in MC3T3-E1 cells transfected with pcDNA-NDRG2 (Figure 2A, 2B) and decreased in MC3T3-E1 cells transfected with shRNA-NDRG2-1 and shRNA-NDRG2-2 ( Figure 2C) . And, NDRG2 expression in shRNA-NDRG2-1 group was less than that in shRNA-NDRG2 group (Figure 2C, 2D) . Therefore, shRNA-NDRG2-1 was selected for the subsequent experiment. As shown in Figure 3A , BMP2 induction could promote the expression of Runx2, OPG, OSX, and OCN in BMP2-induced MC3T3-E1 cells. And NDRG2 upregulation further increased the expression of Runx2, OPG, OSX, and OCN in BMP2-induced MC3T3-E1 cells. However, NDRG2 downregulation decreased the expression of Runx2, OPG, OSX, and OCN in BMP2-induced MC3T3-E1 cells. As shown in Figure 3B , the ALP expression was increased when the MC3T3-E1 cells were treated with BMP2 and NDRG2 upregulation further promoted the ALP expression in BMP2-induced MC3T3-E1 cells. However, NDRG2 downregulation inhibited the ALP expression in BMP2-induced MC3T3-E1 cells. Therefore, NDRG2 overexpression could promote the osteoblast differentiation while NDRG2 downregulation was the opposite.
Upregulation and downregulation of NDRG2 affects the osteoblast calcification
BMP2 could increase the calcium deposit in MC3T3-E1 cells and NDRG2 upregulation further promoted the calcium deposit in BMP2-induced MC3T3-E1 cells. However, NDRG2 downregulation decreased the calcium deposit in BMP2-induced MC3T3-E1 cells (Figure 4 ). Therefore, NDRG2 upregulation could increase the osteoblast calcification while NDRG2 downregulation was the opposite.
Upregulation and downregulation of NDRG2 affects the JAK3/STAT3 signaling pathway As shown in Figure 5 , the phosphorylation levels of JAK3 and STAT3 were increased in BMP2-induced MC3T3-E1 cells. In addition, NDRG2 upregulation promoted the phosphorylation levels of JAK3 and STAT3 in BMP2-induced MC3T3-E1 cells. However, NDRG2 downregulation inhibited the phosphorylation levels of JAK3 and STAT3 in BMP2-induced MC3T3-E1 cells. Therefore, NDRG2 upregulation could activate the JAK3/STAT3 signaling pathway while NDRG2 downregulation was the opposite.
NDRG2 promotes BMP2-induced osteoblast differentiation through the JAK3/STAT3 signaling pathway WHI-P154 is a signaling inhibitor of JAK3/STAT3 signaling pathway. The BMP2-induced MC3T3-E1 cells transfected with pcDNA-NDRG2 were respectively treated with 20 μM and 50 μM WHI-P154 for day 14. WHI-P154 could suppressed the expression of BMP2, Runx2, OPG, OSX, and OCN. The inhibition effects of WHI-P154 were gradually enhance with the increase of WHI-P154 concentration for MC3T3-E1 cells ( Figure 6A ). The ALP expression was decreased when MC3T3-E1 cells treated with WHI-P154 and the expression of ALP in pcDNA-NDRG2+BMP2+WHI-P154 (50 μM) group was less than that in pcDNA-NDRG2+BMP2+WHI-P154 (20 μM) group ( Figure 6B ). As shown in Figure 6C , the intracellular calcium deposit was decreased when MC3T3-E1 cells treated with WHI-P154 and the intracellular calcium deposit in pcDNA-NDRG2+BMP2+WHI-P154 (50 μM) group was less than that in pcDNA-NDRG2+BMP2+WHI-P154 (20 μM) group. The inhibition of JAK3/STAT3 signaling pathway could decrease the expression of BMP2, Runx2, OPG, OSX, OCN, and ALP and calcium deposit. Therefore, NDRG2 accelerated BMP2-induced osteoblast differentiation by the JAK3/STAT3 signaling pathway.
Discussion
The effect of NDRG2 on osteoblastic differentiation and calcification through the JAK3/STAT3 signaling pathway was explored. The experimental results indicated that NDRG2 promoted BMP2-induced osteoblastic differentiation and calcification by activating JAK3/STAT3 signaling pathway.
According to the International Osteoporosis Foundation (IOF), about 15% to 30% of men was affected by osteoporosis while the ratio in women could reach to 30% to 50%, who needed to pay special attention to osteoporosis prevention and treatment at the right age [10] . Hormone replacement treatment (HRT) is usually used in postmenopausal osteoporosis (PMOP) therapy. However, long-term use of chemical synthetic hormones may cause hyperplasia and cancerization of the reproductive system and the occurrence of cardiovascular and cerebrovascular diseases [11] [12] [13] .
BMP2 is the only growth factor inducing the mesenchymal cells to differentiate into bone tissues. In the early stage of bone formation, BMP2 can not only recruit undifferentiated mesenchymal cells into bone formation to differentiate into bone cells, but also reverse the differentiation of fibroblast myoblasts and bone marrow basal cells into bone cells [14] .
